Healthcare M&A in Third Quarter

FOR IMMEDIATE RELEASE
Stephen M. Monroe, Partner
Sanford B. Steever, Editor
800-248-1668
203-846-6800
Fax: 203-846-8300
pressreleases@levinassociates.com
Health Care Merger And Acquisition Activity Surges In Third Quarter 2005, According To Irving Levin Associates, Inc.
NEW CANAAN, CT – October 12, 2005 – According to a new Report from Irving Levin Associates, a total of $57.5 billion was committed to finance the third quarter’s health care merger and acquisition activity. This figure represents more than half of the $111.8 billion committed during the first three-quarters of 2005 to the M&A market, and underscores growing investor confidence and participation in the health care industry.

THE HEALTH CARE M&A MARKET THIRD QUARTER 2005 DOLLAR AMOUNTS BY SECTOR*
Sector
Dollar Amount (Q3:05)
Percent of  Quarter
Dollar Amount (Q2:05)
Percent of Quarter
Dollar Amount (Q3:04)
Percent of  Quarter
Managed Care
$17.3B
30%
$720.0 M
4%
$1.1 B
6%
Long-Term Care
3.0 B
5%
1.0 B
5%
487.0 M
3%
Labs, MRI, Dialysis
1.9 B
3%
4.0 B
21%
196.0 M
1%
Hospitals
1.3 B
2%
975.0 M
5%
4.0 B
23%
Home Health Care
153.0 M
<1%
100.0 M
<1%
12.6 M
<1%
Rehabilitation
48.6 M
<1%
42.3 M
<1%
150.0 M
1%
Physician Groups
9.7 M
<1%
27.5 M
<1%
6.5 M
<1%
Behavioral Health Care
4.7 M
<1%
41.0 M
<1%
444.0 M
2%
Other Services
9.9 B
17%
591.0 M
3%
1.8 B
10%
   Services subtotal
$33.6 B
58%
$7.5 B
39%
$8.2 B
47%
Pharmaceuticals
$12.6 B
22%
3.4 B
18%
5.8 B
33%
Biotechnology
7.8 B
14%
$4.7 B
25%
$338.0 M
2%
e-Health
2.6 B
5%
482.0 M
3%
282.0 M
1%
Medical Devices
874.0 M
<1%
2.9 B
15%
3.0 B
17%
  Technology subtotal
$23.9 B
42%
$11.5 B
61%
$9.4 B
53%
 
 
 
 
 
 
 
Total health care
$57.5 B
100%
$19.0 B
100%
$17.6 B
100%
*Preliminary figures

 “The third quarter saw increased support for the services sectors as investors put more capital there than in the corresponding technology sectors, reversing a trend of the past three years,” observed Stephen M. Monroe, Managing Editor at Irving Levin Associates. “Nearly 60% of the funds committed in the third quarter went to finance health care services deals, including six of the quarter’s 10 billion-dollar deals. The Managed Care sector alone posted three such transactions, totaling $16.9 billion.”
“The Managed Care sector has recently seen strong M&A activity as companies try to gain market share and position themselves for opportunities and challenges as Medicare Part D comes on line next year,” observed Sanford Steever, Ph.D., editor of the Report. “The drug benefit program associated with Part D is also helping to promote mergers and acquisitions in the Pharmaceuticals sector. Big pharma continues a two-pronged strategy to prepare for the implementation of the new program. On the one hand, they are buying late-stage biotechs to gain new branded drugs, which will be under less competition from generics, and, on the other hand, they are acquiring generic equivalents of drugs going off patent so they can better compete as Part D ripples through the economy.”
THE HEALTHCARE M&A MARKET THIRD QUARTER 2005
DEAL VOLUME BY SECTOR*
 
Q3:05
Q2:05
%
Q3:04
%
Sector
Deals*
Deals
Change
Deals
Change
Services Segment:
 
 
 
 
 
Long-Term Care
29
30
    -3%
26
+12%
Home Health Care
20
15
+33%
8
+150%
Hospitals
16
15
    +7%
17
-6%
Managed Care
13
6
    +117%
10
+30%
Physician Medical Groups
8
8
    0%  
4
+100%
Laboratories, MRI, Dialysis
7
14
-50%
9
-22%
Behavioral Health Care
3
5
-40%
7
-57%
Rehabilitation
1
5
-80%
3
-67%
Other
   44
  29
     +52%
  26
   +69%
    Services Subtotal
141
127
      +11%
110
+28%
Technology Segment:
 
 
 
 
 
Pharmaceuticals
41
25
    +64%
48
-15%
Medical Devices
33
37
    -11%
30
+10%
Biotechnology
22
26
    -15%
15
+47%
e-Health
  14
  11
    +27%
   13
  +8%
    Technology Subtotal
110
99
    +11%
106
+4%
 
 
 
 
 
 
Grand Total
251
226
    +11%
216
+16%
*Preliminary figures
Transactions in the third quarter clustered primarily around two areas. First, acquisitions of acute, home health and senior care facilities, involving the Hospital, Home Health and Long-Term Care sectors, accounted for 26% of the quarter’s deal volume. Second, the two drug-producing sectors, Pharmaceuticals and Biotechnology, accounted for an additional 25% of that volume. The contribution of each individual sector to this volume appears in the table above, where each appears in the health care services or the technology segment.
The broad availability of capital through the stock market and private equity firms, coupled with low interest rates, will continue to feed health care M&A activity through the remainder of 2005. “Dealmaking should continue unabated for the rest of the year, reaching nearly $140 billion and 1,000 deals, with drug-producers dominating the technology segment and facility operators leading services,” stated Mr. Monroe.
For more information on The Health Care M&A Report, or for a subscription to any Irving Levin publication, call 800-248-1668. Irving Levin Associates, Inc., established in 1948, has its headquarters in Norwalk, CT and is online at www.levinassociates.com. This privately held corporation publishes research reports and newsletters, and maintains merger and acquisition databases, on the health care and senior housing markets.
Click here to get more information or to order any of our Publications.
Back to top